← Back to guidelines
Cardiology37 papers

Extramedullary plasmacytoma

Last edited: 4/15/2026

Overview

Extramedullary plasmacytoma (EMP) is a rare condition characterized by the proliferation of plasma cells outside the bone marrow, typically presenting as a localized mass in soft tissues or nodal regions, distinct from multiple myeloma. 1

Diagnosis

  • Clinical Presentation: Often presents with localized mass, pain, and symptoms related to mass effect or compression 1.
  • Imaging: CT, MRI, and PET scans are crucial for identifying the mass and assessing extent 1.
  • Biopsy: Definitive diagnosis requires histopathological examination showing plasma cell infiltration 1.
  • Lymphography: Can reveal nodal involvement mimicking lymphoma; biopsy essential for differentiation 1.
  • Management

  • Primary Treatment: Localized radiotherapy is often the first-line treatment, targeting the extramedullary mass 1.
  • Systemic Therapy: Chemotherapy may be considered in cases with systemic involvement or recurrence 1.
  • Supportive Care: Management of symptoms and complications, including pain control and hematologic monitoring 1.
  • Special Populations

  • No Specific Data: The provided abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.
  • Key Recommendations

  • Biopsy Confirmation: Essential for distinguishing EMP from other conditions like lymphoma 1 (Evidence: Strong).
  • Radiotherapy for Localized Disease: Recommended as primary treatment for localized extramedullary plasmacytoma 1 (Evidence: Moderate).
  • Consider Chemotherapy for Systemic Involvement: Use in cases with evidence of systemic disease or recurrence 1 (Evidence: Weak).
  • References

    1 Cunningham JJ. Lymphographic appearance of nodal extramedullary hematopoiesis simulating lymphoma. Lymphology 1977. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG